• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Novo Nordisk settles US patent litigation case on Victoza (liraglutide) with Teva

cafead

Administrator
Staff member
  • cafead   Mar 20, 2019 at 12:32: PM
via A settlement between Novo Nordisk and Teva Pharmaceuticals USA (Teva) has been reached on the US patent litigation case for Victoza (liraglutide).

article source
 

<